Harnessing the power of patient samples to diagnose, understand and treat rare immune diseases
28 February 2018
Finkel Theatre, John Curtin School for Medical Research, Canberra, Australia
Hosted by Centre for Personalised Immunology
The Centre for Personalised Immunology is proud to present a public lecture with two of their lead investigators speaking.
28/02/18 5.30pm Finkel Theatre, John Curtin School of Medical Research
Rapid advances in the speed and cost of DNA sequencing technology are changing our understanding of human disease. By sequencing a patient’s genetic code, changes can be identified that are likely to be disease-causing, an approach that has particular relevance to rare disease. By knowing the DNA sequence in such an individual, we can then study the way genetic changes affect how the body functions, and therefore how diseases arise in the first place. This understanding is critical, as it can open up new treatments that would otherwise never have been considered.
The immediate research challenge however is not only to look for new genetic changes in individual patients, but to prove that those changes are responsible for causing disease. To do so, researchers and clinicians must work together with affected patients, to decipher the genetic code, analyse blood cells, and create laboratory models that can shed light on the effects of such changes.
Coinciding with ‘Rare Disease Day’, this lecture will outline how clinicians and researchers at the Centre for Personalised Immunology are working together with patients to identify and understand the genetic cause of rare immune diseases, using lupus and immunodeficiency as examples, and how this endeavour has the potential to uncover better ways to treat affected patients.